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Background: Sensory hypersensitivities are common phenomena in migraine. We examined the role of sensory
hypersensitivities on suicidality in patients with migraine.
Methods: Patients with migraine (with or without aura) were consecutively recruited from our headache clinic. We
asked them if they experienced photophobia, phonophobia, osmophobia, and allodynia during migraine attack.
The Mini International Neuropsychiatric Interview was used to diagnose current major depressive disorder (MDD),
current generalized anxiety disorder (GAD) and suicidality.
Results: Among 220 subjects, 25.5 % had current MDD, 17.3 % had current GAD, and 31.8 % had suicidality.
Patients with suicidality were more like to have a low household income, chronic migraine (CM), medication
overuse headache, high headache intensity, osmophobia, allodynia, high disability, MDD, and GAD than those
without suicidality. The strongest risk factor for suicidality by multivariate analyses was osmophobia (adjusted Odds
Ratio [AOR] 3.12, 95 % confidence interval [CI] 1.57-6.21, p = 0.001), followed by current MDD (AOR 2.99, 95 % CI
1.33-6.76, p = 0.008), CM (AOR 2.48, 95 % CI 1.21-5.09, p = 0.013), current GAD (AOR 3.11, 95 % CI 1.22-7.91, p = 0.017),
and allodynia (AOR 2.72, 95 % CI 1.19-6.21, p = 0.018).
Conclusions: Osmophobia and allodynia are critical factors for suicidality in patients with migraine, after controlling for
depression, anxiety, and CM.
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Adolescent and adult patients with migraine have been
known to have a high risk of suicidality including sui-
cidal ideation and attempt [1–6]. Risk factors for devel-
oping suicide in patients with migraine were psychiatric
disorders [1–6], female gender [2], migraine with aura
[1–3], higher headache frequency [3] and pain intensity
[4, 6], younger age [5], unmarried state [5], and higher
disability [5]. Among them, migraine with aura has been
chosen as a migraine-specific factor for suicide after
controlling for age, gender, major depression, and anx-
iety disorders [1–3].
Sensory hypersensitivities such as photophobia, pho-
nophobia, osmophobia, and allodynia were frequently
observed in patients with migraine [7–12]. Although the* Correspondence: sppark@mail.knu.ac.kr
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in any medium, provided the original work is pfrequency of allodynia is widely variable (15.1 % to
69.7 %) [10–12], the frequencies of photophobia, phono-
phobia, and osmophobia were in the range from 43 % to
86 % [7–9, 11, 12]. Recently, a hospital-based study in
Taiwan reported that patients with osmophobia were
more likely to have higher level of depression and anxiety
than those without osmophobia [7]. In addition, patients
with allodynia had a higher frequency of anxiety thacn
those without allodynia and those with moderate to severe
allodynia had a higher risk of developing depression than
those with no or mild allodynia [11].
Despite the significance of migraine with aura for suicid-
ality, relevant studies did not consider sensory hypersensi-
tivities as risk factors of suicide despite the existence of
the relationship between sensory hypersensitivities and
psychiatric symptoms [7, 11]. Therefore, we investigated
whether sensory hypersensitivities contributed to suicidality
in patients with migraine.Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Park et al. The Journal of Headache and Pain  (2015) 16:44 Page 2 of 6Methods
Subjects
We invited new patients with migraine who had con-
secutively visited a headache clinic in the Department of
Neurology at Kyungpook National University Hospital
since September 2013. Patients were adolescents and
adults between the ages of 15 and 75. They were newly
diagnosed patients at the visit or already diagnosed pa-
tients but did not take preventive medicines for mi-
graine and other psychotropic agents within a month.
A diagnosis of migraine was assigned based on the
International Classification of Headache Disorders, 3rd
edition, beta version (ICHD-3 beta) by a trained neurolo-
gist (SP Park) [13]. Patients who had illiteracy, mental re-
tardation, serious medical, neurological, or psychiatric
disorders, and alcohol or drug abuse that prevented them
from cooperating in the psychiatric interview and under-
standing the questionnaire were excluded. Patients who
had a probable migraine or who declined to participate in
the interview were also excluded.
Study design
A cross-sectional study was conducted as part of a
hospital-based study which examined the impact of psy-
chiatric disorders on migraine. The Institutional Review
Board of Kyungpook National University Hospital ap-
proved the study. All participants obtained written in-
formed consent. SP Park interviewed each patient and
reviewed the patient’s medical charts to collect demo-
graphic and clinical information for a computerized data-
base. Sociodemographic data were collected on variables
including age, gender, education, place of residence (city
or country), religion, employment, household income
(earning at least three million KRW per month, equivalent
to 2800 USD per month or not), and marital status (mar-
ried or unmarried, divorced, and bereaved). Clinical data
included; type of migraine, migraine chronicity (episodic
migraine [EM] or chronic migraine [CM]), medication
overuse headache (MOH), age at onset, disease duration,
headache intensity, accompanying symptoms (presence of
nausea and/or vomiting, photophobia, phonophobia,
osmophobia, or allodynia) and family history. The Visual
Analog Scale (VAS) measured headache intensity. The
VAS was measured in two different ways, i.e. the VASmax
and VASnow. VASmax meant the maximal intensity of
headaches experienced during the prior three months, and
VASnow represented the intensity of the headache on the
day of the psychiatric interviews. Photophobia, phonopho-
bia, and osmophobia were defined as the hypersensitivity
to light, sound, and certain odors during migraine attacks
which could cause avoidance of those stimulations or ag-
gravation of migraine symptoms. We asked patients
whether they experienced symptoms in the preceding
year. Allodynia was measured using the 12-item AllodyniaSymptom Checklist (ASC-12) [14] with a cut-off score
of >2 defining allodynic patients. Family history of mi-
graine was defined as the existence of migraine diagnosis
in a lineal ascendant and siblings. Migraine disability was
measured by the Migraine Disability Assessment Scale
(MIDAS) [15]. The overall level of disability was repre-
sented as follows; grade I, little or no disability (score of
0–5), grade II, mild disability (6–10), grade III, moderate
disability (11–20), and grade IV, severe disability (21 or
more). Disability of grade I and II was compared to that of
grade III and IV.
Psychiatric interviews
All participants were interviewed by a neuropsychologist
within a week after the first visit to determine whether
they had current major depressive disorder (MDD),
current generalized anxiety disorder (GAD) or suicidality
using the Korean version of the Mini-International
Neuropsychiatric Interview-Plus 5.0.0. (MINI) [16]. The
MINI is a brief, structured interview based on DSM-IV
criteria [17], and is recommended to screen for psychi-
atric comorbidity in headache patients [18]. The Kappa
values of MDD and GAD in the Korean version were
0.71 and 0.57, respectively, which exhibited good agree-
ment between the MINI and the expert’s diagnosis. The
suicidality module is composed of six questions of differ-
ent weight, including five questions asking about current
suicidality (which includes suicidal ideation or attempt
in the preceding month: wish for death [weight 1], wish
for self-harm [weight 2], suicidal thought [weight 6], sui-
cide plan [weight 10], and suicide attempt [weight 10],
and one question asking the lifetime suicide attempt
[weight 4]). If respondents said “yes” for at least one of
the six questions, they were thought to have suicidality.
The degree of current suicidality is estimated from the
sum of the weighted score of the six questions, with low
(1–5), moderate (6–9), and high (≥10) level of suicide
risk.
Statistical analyses
The Statistical Package for the Social Sciences (SPSS ver-
sion 19.0) was used for the analyses of data. Descriptive
statistics are presented in terms of counts, percentages,
means, and standard deviations. To determine factors
for suicidality, a logistic regression model with suicidality
as the outcome was developed, using a two-step proced-
ure. First, univariate logistic regression analyses were
used to test which potential variables were associated
with suicidality among patients with migraine. Second,
all variables with a statistically significant univariate ef-
fect were entered in a multivariate logistic regression
model and a forward likelihood ratio test was chosen to
assess the differential contribution of individual variables
to suicidality. Results were reported as odds ratio (OR)
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coefficients (Beta) and corresponding p values. The level
of statistical significance was set at p < 0.05.
Results
A total of 254 patients with migraine consecutively visited
our headache clinic. Among them, 34 patients were ex-
cluded because of refusal to interview (n = 12), probable
migraine (n = 10), taking preventive medicine within a
month (n = 4), age older than 75 (n = 4), mental retard-
ation (n = 2), or illiteracy (n = 2). Subsequently, 220 pa-
tients (30 men/190 women, mean age 40.1 ± 13.1)
completed the study. Among them, 17 patients (7.7 %)
had migraine with aura and 203 patients (92.3 %) had mi-
graine without aura. EM was manifested in 95 patients
(43.2 %), CM in 125 patients (56.8 %), and MOH in 52 pa-
tients (23.6 %). All patients with MOH had CM. Photo-
phobia, phonophobia, osmophobia, and allodynia were
manifested in 104 patients (47.3 %), 140 patients (63.6 %),
108 patients (49.1 %), and 39 patients (17.7 %), respect-
ively. Current MDD and current GAD were revealed in 56
patients (25.5 %) and 38 patients (17.3 %), respectively.
Suicidality was documented in 70 patients (31.8 %).
Among them, 25 patients (35.7 %) had a moderate to high
degree of suicidality. Current suicidality, lifetime suicide
attempt, or both were revealed in 38 patients (54.3 %), 18
patients (25.7 %), and 14 patients (20 %), respectively.
Forty patients (57.1 %) had only suicidal ideation and 30
patients (42.9 %) had current or lifetime suicidal attempt.
Sociodemographic, clinical, and psychiatric aspects of
migraine with respect to suicidality are listed in Table 1.
Factors contributing to suicidality by univariate analyses
are documented in Table 2. Patients with suicidality were
more like to have a low household income (OR 1.88,
95 % confidence interval [CI] 1.04-3.41, p = 0.038), CM
(OR 3.05, 95 % CI 1.63-5.69, p < 0.001), MOH (OR 2.27,
95 % CI 1.20-4.32, p = 0.012), high VASmax score (OR
0.80, 95 % CI 0.68-0.94, p = 0.007), high VASnow score
(OR 0.81, 95 % CI 0.72-0.91, p < 0.001), osmophobia (OR
2.98, 95 % CI 1.64-5.41, p < 0.001), allodynia (OR 4.70,
95 % CI 2.27-9.71, p < 0.001), high MIDAS grade (OR
3.05, 95 % CI 1.63-5.69, p < 0.001), current MDD (OR
5.50, 95 % CI 2.87-10.54, p < 0.001), and current GAD
(OR 5.86, 95 % CI 2.77-12.40, p < 0.001) than those with-
out suicidality. Age, gender, education, and the type of
migraine were not associated with suicidality. The fre-
quency of osmophobia or allodynia was not significantly
changed by the degree of suicidality or if patients had
only suicidal ideation or attempted suicide. In addition,
it was not affected by if patients had current suicidality
or lifetime suicidal attempts.
Risk factors contributing to suicidality by multivariate
analyses are documented in Table 3. The strongest risk
factor for suicidality was osmophobia (Beta 0.314, adjustedOR [AOR] 3.12, 95 % CI 1.57-6.21, p = 0.001), followed
by current MDD (Beta 0.264, AOR 2.99, 95 % CI 1.33-
6.76, p = 0.008), CM (Beta 0.249, AOR 2.48, 95 % CI
1.21-5.09, p = 0.013), current GAD (Beta, 0.237, AOR
3.11, 95 % CI 1.22-7.91, p = 0.017), and allodynia (Beta
0.211, AOR 2.72, 95 % CI 1.19-6.21, p = 0.018). A forward
likelihood ratio test produced a five-variable model that
explained 34.3 % of the variance in suicidality. According
to Beta, the contribution of osmophobia to suicidality
was 1.19 times greater than that of current MDD, 1.26
times greater than that of CM, 1.32 times greater than
that of current GAD, and 1.49 times greater than that
of allodynia.
Discussion
Sensory hypersensitivities such as photophobia and
phonophobia were frequently observed in patients with
migraine and included in the diagnostic criteria of mi-
graine of the International Classification of Headache
Disorders (ICHD)-3 beta [13]. The other types of hy-
persensitivities, osmophobia and allodynia, were also
frequently manifested in patients with migraine [7–12],
but were not included in the diagnostic criteria of mi-
graine. Although osmophobia has been reported as one
of the specific symptoms for differentiating migraine
from other headache disorders [7–9], it remains under-
recognized as a migraine-associated symptom, and its clin-
ical implications are under-investigated [7]. Under these
circumstances, we found that osmophobia and allodynia
were major risk factors for suicidality in patients with mi-
graine, after controlling for MDD, GAD, and CM.
Regarding risk factors for suicidality in patients with
migraine, several studies reported psychiatric disorders,
sociodemographic factors, type of migraine, headache
frequency and intensity, and migraine disability [1–6].
We also found similar results in univariate analyses.
However, sensory hypersensitivities, such as osmophobia
and allodynia, were found to be critical factors by multi-
variate analyses. We also found that the contribution of
osmophobia to suicidality is a little higher and the con-
tribution of allodynia to suicidality is a little lower than
that of depression or anxiety. This means that osmopho-
bia and allodynia are important to determine suicidality
as much as psychiatric disorders.
The mechanism to explain the contribution of osmo-
phobia to suicidality is unknown. One possibility is a
common pathway of osmophobia and mood changes
may provoke suicidality. Smell is innately related to the
limbic system. In an event-related fMRI study, olfactory
stimulation during migraine attack produced increased
limbic and brainstem activity [19]. In mood disorders,
several limbic areas have been reported to be altered in
structural, functional and molecular neuroimaging [20].
Therefore, altered function of the limbic system appears
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and finally can provoke suicidality. However, this theory
may be insufficient to explain the mechanism in our pa-
tients, because osmophobia can contribute to suicidality
regardless of the psychiatric disorders. Another possibil-
ity is osmophobia is associated with headache intensity,
and severe pain accompanying osmophobia may provoke
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Grade I and II
Grade III and IV
Current MDD
Current GAD
Abbreviations: KRW = Korean Won; MOH =medication overuse headache; VAS = Visu
depressive disorder; GAD = generalized anxiety disorder
aMaximal headache intensity during the preceding 3 months
bHeadache intensity on the day of psychiatric interviewsseverity at baseline predicted suicide attempts during the
two-year follow-up period in migraine or non-migraine
headache [4]. In a hospital-based study, headache inten-
sity was a risk factor for suicidal ideation in patients with
migraine after controlling for depression [6]. Through
these results, if osmophobia is an expression for severe
pain, it can be a risk factor for suicidality. Further stud-
ies are needed to elucidate these relationships. Thele subjects (n =220) with respect to suicidality
Mean ± SD (range) or number (%)
Suicidality No suicidality
(n = 70) (n = 150)
40.3 ± 13.2 (16–73) 40.0 ± 13.0 (15–65)
62 (88.6) 128 (85.3)
12.4 ± 2.9 (6–18) 13.0 ± 2.8 (5–18)
61 (87.1) 125 (83.3)
36 (51.4) 81 (54.0)
34 (48.6) 72 (48.0)
41 (58.6) 109 (72.7)
42 (60.0) 95 (63.3)
4 (5.7) 13 (8.7)
66 (94.3) 137 (91.3)
18 (25.7) 77 (51.3)
52 (74.3) 73 (48.7)
45 (64.3) 96 (64.0)
24 (34.3) 28 (18.7)
29.7 ± 12.0 (9–53) 30.5 ± 12.3 (8–59)
10.6 ± 9.4 (0.3-36) 9.4 ± 7.3 (0.2-37)
8.5 ± 1.5 (3–10) 7.7 ± 2.2 (0–10)
3.2 ± 2.6 (0–10) 1.9 ± 2.3 (0–8)
60 (85.7) 132 (88.0)
33 (47.1) 71 (47.3)
51 (72.9) 89 (59.3)
47 (67.1) 61 (40.7)
24 (34.3) 15 (10.0)
42.0 ± 41.4 (0–190) 18.3 ± 21.9 (0–135)
18 (25.7) 77 (51.3)
52 (74.3) 73 (48.7)
34 (48.6) 22 (14.7)
25 (35.7) 13 (8.7)
al Analog Scale, MIDAS =Migraine Disability Assessment Scale; MDD =major
Table 2 Factors contributing to suicidality by univariate
analyses
Variable β SE (β) OR (95 % CI) p value
Age −0.002 0.011 1.00 (0.98-1.02) 0.862
Gender 0.287 0.441 1.33 (0.56-3.16) 0.516
Education 0.076 0.051 1.08 (0.98-1.19) 0.134
Place of residence 0.304 0.419 1.36 (0.60-3.08) 0.468
Religion −0.103 0.29 0.90 (0.51-1.59) 0.722
Employment 0.023 0.29 1.02 (0.58-1.81) 0.937
Household income 0.631 0.304 1.88 (1.04-3.41) 0.038
Marital status 0.141 0.297 1.15 (0.64-2.06) 0.635
Type of migraine −0.448 0.591 0.64 (0.20-2.03) 0.448
CM 1.114 0.319 3.05 (1.63-5.69) <0.001
Family history of migraine 0.012 0.302 1.01 (0.56-1.83) 0.967
MOH 0.821 0.328 2.27 (1.20-4.32) 0.012
Age at onset 0.006 0.012 1.01 (0.98-1.03) 0.640
Disease duration −0.018 0.018 0.98 (0.95-1.02) 0.304
VASmax
a −0.221 0.082 0.80 (0.68-0.94) 0.007
VASnow
b −0.208 0.059 0.81 (0.72-0.91) <0.001
Nausea and/or vomiting −0.201 0.424 0.82 (0.36-1.88) 0.636
Photophobia −0.008 0.290 0.99 (0.56-1.75) 0.979
Phonophobia 0.610 0.316 1.84 (0.99-3.42) 0.054
Osmophobia 1.092 0.304 2.98 (1.64-5.41) <0.001
Allodynia 1.547 0.371 4.70 (2.27-9.71) <0.001
MIDAS grade 1.114 0.319 3.05 (1.63-5.69) <0.001
Current MDD 1.704 0.332 5.50 (2.87-10.54) <0.001
Current GAD 1.767 0.383 5.86 (2.77-12.40) <0.001
Abbreviations: CM = chronic migraine; MOH =medication overuse headache;
VAS = Visual Analog Scale, MIDAS =Migraine Disability Assessment Scale;
MDD =major depressive disorder; GAD = generalized anxiety disorder
aMaximal headache intensity during the preceding 3 months
bHeadache intensity on the day of psychiatric interviews
Park et al. The Journal of Headache and Pain  (2015) 16:44 Page 5 of 6Mechanism for the impact of allodynia to suicidality is a
little easier to explain. Patients with allodynia can reveal
suicidality not only by a high frequency of comorbid de-
pression and anxiety [11, 12] but also by a high probabil-
ity of migraine chronification [10]. Of course, allodyniaTable 3 Factors contributing to suicidality by multivariate
analyses
Variable β SE (β) Betaa Adjusted OR (95 % CI) p value
Constant −2.577 0.547 0.08 <0.001
Osmophobia 1.138 0.351 0.314 3.12 (1.57-6.21) 0.001
Current MDD 1.096 0.416 0.264 2.99 (1.33-6.76) 0.008
CM 0.909 0.367 0.249 2.48 (1.21-5.09) 0.013
Current GAD 1.134 0.476 0.237 3.11 (1.22-7.91) 0.017
Allodynia 1.000 0.422 0.211 2.72 (1.19-6.21) 0.018
Abbreviations: MDD =major depressive disorder; CM = chronic migraine;
GAD = generalized anxiety disorder
aStandardized regression coefficientsmay also be an expression for severe pain. The relation-
ship of them should be clarified.
Our study failed to detect that migraine with aura was
an important risk factor for suicidality. There may be
several reasons to explain such. First, relevant studies
were population-based studies with a large sample sizes
[1–3]. On the other hand, our study was a hospital-
based study, and the number of patients who had mi-
graine with aura was 17. Therefore, the selection bias
may affect the result. Second, previous studies were con-
ducted in adolescents (12–15 years old) [2, 3] or young
adults (21–30 years old) [1] with migraine, but not in
patients of all ages. We investigated risk factors of sui-
cidality in patients who were 15 to 73 years old (mean
40.1 years old). Therefore, the different age groups of eli-
gible patients can elicit different results. In a large sam-
ple, community-based study, migraine with aura was not
a risk factor for suicidal attempt in patients who were 25
to 55 years old (mean 40.4 years old) [4]. A further study
to investigate risk factors according to the different age
groups should be needed. Third, they did not consider
the impact of sensory hypersensitivities on suicidality
[1–3] despite the existence of a relationship between
osmophobia or allodynia and psychiatric symptoms [7,
11]. Fourth, they did not investigate the impact of CM
in relation to episodic migraine (EM) on suicide [1–3].
As expected, CM results in substantially greater disability
than EM. In a hospital-based study in Korea, CM sufferers
were more likely to have depression, anxiety, disability,
and impaired quality of life than EM sufferers [12]. In a
review of the literatures, authors summarized that pa-
tients with chronic daily headache such as CM and
chronic tension-type headache appears to have a high
suicidal intent due to depression, disability, impaired
quality of life and chronic pain [21]. Therefore, CM
should be included as a variable to determine suicide.
After all, if we investigate risk factors for suicidality in
patients with migraine considering these issues, more
precise data will be obtained.
Our study has some limitations. First, this is a hospital-
based study, which may not represent the whole migraine
population. Therefore, a large sample, population-based
study should be done. Second, the cross-sectional nature
of our study prevented us from drawing conclusions about
the causal relationship between osmophobia or allodynia
and suicidality. A longitudinal study is needed. Third, eth-
nic differences could also limit the generalization of our
results, for example, our patients revealed a higher fre-
quency of osmophobia and a lower frequency of allodynia
than Western patients did. Further studies to prove our
results should also be conducted in Western countries.
Fourth, we did not measure olfactory function during the
ictal period of the migraine. Subjective feelings and object-
ive findings of olfaction may draw different conclusions.
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organic diseases on suicidality. However, we excluded
patients who had serious medical, neurological, or psychi-
atric disorders from the study, so the impact of other or-
ganic diseases on suicidality is likely to be trivial.
Conclusions
Suicide is the tenth leading cause of death worldwide
[22] with about 800,000 to one million people dying an-
nually, giving a mortality rate of 11.6 per 100,000 per-
sons per year [23]. In a two year population-based
observational study, suicidal attempt is 4.43 times higher
in patients with migraine than in healthy controls when
sex, psychiatric disorder, and previous history of suicidal
attempts had been adjusted for at baseline [4]. Almost
32 % of our patients manifested suicidality and nearly
43 % of them attempted suicide when they visited a
tertiary care hospital. Under these circumstances, clini-
cians should always observe carefully the existence of
suicidality in patients with migraine who visit out-
patient clinics. In a busy clinical setting, psychiatric in-
terviews, including suicidality, take a long time to
conduct. In this situation, simply asking the patients
about osmophobia or allodynia will be an initial step
for further evaluation of suicidality. A global study to
evaluate sensory hypersensitivities as a red flag for sui-
cidality should be done in the future.
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